Tiếp theo

Tự chạy

Dr. Aleksander Sekulic on Vismodegib in Patients with Basal Cell Nevus Syndrome

2 Lượt xem • 07/01/23
Đăng lại
Nhúng
administrator
administrator
Người đăng ký
0

Aleksandar Sekulic, MD, PhD, Assistant Professor of Dermatology, Mayo Clinic, Scottsdale, AZ, explains the positive data that came from a recent study of the hedgehog pathway inhibitor vismodegib. Vismodegib decreased the size of existing basal cell carcinomas and reduced the number of new basal cell carcinomas in patients with basal cell nevus syndrome (Gorlin syndrome).

For more information visit: http://targetedhc.com/

Cho xem nhiều hơn
0 Bình luận sort Sắp xếp theo
Bình luận trên Facebook

Tiếp theo

Tự chạy